Get the SPI Wire

Indaptus Therapeutics, Inc.

Annual Meeting

of Shareholders

MEETING DATE

08/10/2026
DEF 14A FILED
07/16/2026
PUBLISHED
07/16/2026 8:35 pm
TIME TO PUBLISH
07/18/2026
METHODOLOGY
approve

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
0
AGAINST
0
WITHHOLD
3
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
ELECTION OF DIRECTORS
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the Board unanimously recommends FOR each Class II director nominee.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Haskell & White LLP served in 2025, and the filing discloses no direct or indirect financial interest.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
THE 2026 PLAN PROPOSAL
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the 2021 Plan will terminate for future grants if the 2026 Plan is approved.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates